GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Advanced Biomed Inc
Advanced Biomed's value as an oncology biotech company is determined by the progress of its clinical programs. The potential share price will depend on trial results, regulatory decisions, and the commercial potential of its developments.
Share prices of companies in the market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company focused on developing new cancer treatments. We've categorized it as a "Cancer Treatment" company, and the chart below shows how investors value companies at the forefront of cancer treatment.
Broad Market Index - GURU.Markets
Advanced Biomed is a biopharmaceutical company developing innovative treatments for cancer and other serious diseases. Its focus on oncology makes it a prominent player in the GURU.Markets index. The chart below represents the entire market. Find out how Advanced Biomed compares to it.
Change in the price of a company, segment, and market as a whole per day
ADVB - Daily change in the company's share price Advanced Biomed Inc
For Advanced Biomed Inc., an oncology company, daily volatility reflects sensitivity to scientific data and progress in drug development. This metric is an important element in formulas assessing risks and potential in biotech.
Daily change in the price of a set of shares in a market segment - Cancer cure
Advanced Biomed is an early-stage biotech company, meaning its shares are highly volatile. The chart below shows the average level of volatility in the biotech sector. It helps us understand how the risks inherent in the company's business model align with industry expectations.
Daily change in the price of a broad market stock, index - GURU.Markets
Advanced Biomed is a biotech company developing drugs to treat oncology. Its shares are buoyed by anticipation of clinical trial results. These sharp, event-driven movements are part of a complex mosaic of stock market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Advanced Biomed Inc
Advanced Biomed Inc's year-over-year performance is a story of developing innovative cancer treatments. Its 12-month market capitalization is entirely dependent on progress in preclinical and clinical trials. Every successful step confirms the potential of its scientific platform and brings the development of new, more effective drugs closer.
Annual dynamics of market capitalization of the market segment - Cancer cure
As an early-stage biotech company, Advanced Biomed is a high-risk bet on science. Its performance is completely disconnected from the sector and depends on news about the clinical trials of its cancer drugs. Its stock price will reflect investors' speculative belief in the potential of its developments.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Advanced Biomed is a speculative biotech stock, where all its value lies in the potential of its cancer research. Its performance relative to the market is a pure play on lab news. Positive data can trigger explosive growth, while a setback will devalue the stock.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Advanced Biomed Inc
Advanced Biomed is a biopharmaceutical company. Its monthly price performance is typical for the sector: it depends on progress in its scientific developments and clinical programs. News of trial results or funding raises are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Cancer cure
Advanced Biomed is an early-stage biotech company focused on developing cancer treatments. Its future depends on success in research and clinical trials. The chart below shows the overall dynamics of the biotech sector, which is the backdrop for the development of such innovative startups.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Advanced Biomed is an early-stage biotech company focused on cancer treatment. Its shares are pure venture capital bets. Their price is completely unrelated to the market and will only react to the earliest news from the lab, making them highly speculative.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Advanced Biomed Inc
Advanced Biomed is an early-stage biomedical company, where value is created in the lab rather than in manufacturing. Its weekly price movement is virtually disconnected from overall market trends and is a direct response to scientific events. The publication of preclinical data, the receipt of a patent, or a presentation at a medical conference can trigger sharp fluctuations, reflecting investors' constant reassessment of its future potential.
Weekly dynamics of market capitalization of the market segment - Cancer cure
Advanced Biomed Inc. is focused on developing cancer treatments. For companies like this, news about clinical trials is a key driver. This chart helps us understand whether the weekly ups and downs in the stock are the result of unique events or a general trend across the biotech sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Advanced Biomed Inc. is a biotech company whose stock moves in sync with clinical trial news. This chart is a great way to see how its weekly fluctuations are disconnected from overall market trends. Is the company living its own life, or is it being affected by the global sell-off?
Market capitalization of the company, segment and market as a whole
ADVB - Market capitalization of the company Advanced Biomed Inc
The data on Advanced Biomed Inc (ADVB) may be inaccurate. The chart of such a biotech company, if it exists, would likely reflect speculative interest in its early-stage oncology developments. Its market cap would be highly volatile and dependent on research news.
ADVB - Share of the company's market capitalization Advanced Biomed Inc within the market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company developing cancer treatments. In this highly competitive segment, its market capitalization reflects the potential of its scientific research. Its dynamics are a sensitive barometer of news on the progress of clinical trials, which determine the company's future.
Market capitalization of the market segment - Cancer cure
Advanced Biomed develops drugs to treat cancer. How big is this arena? The chart below shows the pulse of the entire cancer treatment sector. Its high volatility reflects both the enormous hopes for new breakthrough drugs and the high risks associated with their development and clinical trials.
Market capitalization of all companies included in a broad market index - GURU.Markets
Advanced Biomed's chart reflects the venture-stage stage of cancer drug development. Its extremely low market cap is essentially a lottery ticket for success in its early research. It's a chart that illustrates the extreme risk and uncertainty in biotech.
Book value capitalization of the company, segment and market as a whole
ADVB - Book value capitalization of the company Advanced Biomed Inc
Advanced Biomed's book value (likely private) would reflect its physical foundation: laboratories, cell therapy equipment, and financial reserves for cancer research. A chart would show how the company built this physical foundation for its scientific developments.
ADVB - Share of the company's book capitalization Advanced Biomed Inc within the market segment - Cancer cure
Advanced Biomed Inc. is a biopharmaceutical company whose tangible assets are research laboratories focused on developing cancer drugs. The chart shows the share of this specialized R&D infrastructure in its therapeutic niche that this innovative company controls.
Market segment balance sheet capitalization - Cancer cure
Advanced Biomed is a biotechnology company. The pharmaceutical industry, as the graph shows, is both knowledge- and capital-intensive. Advanced Biomed focuses on drug development, and its capital is intellectual property and R&D infrastructure for clinical trials.
Book value of all companies included in the broad market index - GURU.Markets
Advanced Biomed's assets are not factories, but capital and intellectual property focused on developing new treatments for cancer and other diseases. The book value reflects the company's financial resources for its research and development programs.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Advanced Biomed Inc
Advanced Biomed is an early-stage biotech company. Its market capitalization is a speculative valuation of its science. The chart shows the extreme volatility typical of such companies, whose fate depends on future data.
Market to book capitalization ratio in a market segment - Cancer cure
Advanced Biomed is an early-stage biopharmaceutical company developing cancer treatments. Its value is a pure reflection of investor expectations. The chart shows that its market capitalization is a bet on the future success of its research and development, not on its current assets.
Market to book capitalization ratio for the market as a whole
Advanced Biomed is a biotech company focused on cancer treatment. Its market capitalization is a bet on the success of its research and development. This chart illustrates the vast gap between the value of its tangible assets and investor valuations based on life-saving potential and future sales.
Debts of the company, segment and market as a whole
ADVB - Company debts Advanced Biomed Inc
Advanced Biomed is a biomedical company working on cancer drug development. Oncology drug development is one of the most expensive and risky processes in science. This chart shows how the company raises funds from investors to finance its multi-year research and clinical trials in hopes of creating an effective treatment.
Market segment debts - Cancer cure
Advanced Biomed is an early-stage biopharmaceutical company. Like most companies in this field, it has no sales revenue and is entirely funded by venture capital and equity. This chart reflects its current financial headroom, which is necessary for conducting expensive research.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Advanced Biomed Inc
Advanced Biomed is likely a biotech company working on cancer treatments. This chart shows its reliance on external funding. As with any development-stage biotech, debt is a huge risk. Funding should be equity-based to avoid creditor pressure during the long and unpredictable research process.
Market segment debt to market segment book capitalization - Cancer cure
Advanced Biomed is likely in the early stages of developing cancer treatments. Biotech startups require significant venture capital to conduct research. A graph of the total debt burden in the pharmaceutical industry highlights the enormous financial barriers such companies face in developing new treatments.
Debt to book value of all companies in the market
Advanced Biomed Inc. is an early-stage biopharmaceutical company working on cancer treatments. With no products on the market, it is entirely dependent on investor capital. This chart clearly shows that debt financing is unavailable for such risky scientific projects, and their future depends solely on faith in their research platform.
P/E of the company, segment and market as a whole
P/E - Advanced Biomed Inc
For Advanced Biomed, a cancer treatment company, the P/E ratio is not a meaningful metric. The company likely lacks consistent profitability. Its valuation on this chart is arbitrary. Its true value is determined by the potential of its scientific developments and clinical trial results.
P/E of the market segment - Cancer cure
Advanced Biomed is a biomedical company focused on the development and commercialization of novel cancer treatments. This chart shows the average valuation for the sector, providing investors with context for evaluating the company's research portfolio and the risks associated with oncology drug development.
P/E of the market as a whole
Advanced Biomed is a biopharmaceutical company specializing in cancer treatment. Its valuation depends entirely on the success of its drugs in clinical trials and regulatory approval. The overall market sentiment reflected in this chart is completely irrelevant.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Advanced Biomed Inc
Advanced Biomed is an early-stage biopharmaceutical company focused on developing new cancer treatments. This chart reflects investors' speculative expectations for its research. The company's valuation is based solely on the long-term potential of its developments, not on any current financial metrics.
%20P%2FE%20Advanced%20Biomed%20Inc&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Advanced-Biomed-Inc&v=1772543744928 "Chart of the company's future (projected) P/E Advanced Biomed Inc")
Future (projected) P/E of the market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company focused on developing cancer treatments. Its valuation relative to other oncology biotechs reflects investor sentiment about its scientific platform and drug candidates. This demonstrates the market's confidence in its ability to successfully complete clinical trials and reach the market.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Cancer-cure&v=1772543744942 "Future (projected) P/E graph of the market segment - Cancer cure")
Future (projected) P/E of the market as a whole
Advanced Biomed, as its name suggests, is an early-stage biopharmaceutical company focused on cancer treatment. Its valuation is a bet on the success of its scientific developments. This chart reflects the overall risk appetite of investors, which is a key factor in funding long-term and capital-intensive oncology research.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772543745044 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Advanced Biomed Inc
Advanced Biomed is an early-stage biopharmaceutical company focused on developing new cancer treatments. The financial metrics shown in the chart represent investments in research. The company's future depends entirely on the success of its developments in the preclinical and clinical stages.
Profit of companies in the market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company developing cancer treatments. This chart is a health indicator for the entire oncology biotech sector. It shows the risks and costs of development, and how often clinical trial successes or failures impact the entire industry.
Overall market profit
Advanced Biomed is likely in the early stages of cancer drug development. For such companies, fundamental value is determined solely by the scientific potential of their developments. The macroeconomic cycles reflected in this chart only affect the ability to attract funding, not the science itself.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Advanced Biomed Inc
Advanced Biomed is a biotech company developing cancer treatments. Its future profit forecast is a long-term bet on the success of its research. This chart reflects analysts' confidence in the potential of its developments and their chances of commercialization.
%20profit%20of%20the%20company%20Advanced%20Biomed%20Inc&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Advanced-Biomed-Inc&v=1772543745146 "Graph of future (projected) profit of the company Advanced Biomed Inc")
Future (predicted) profit of companies in the market segment - Cancer cure
Advanced Biomed is likely an early-stage biopharmaceutical company focused on developing new cancer treatments. The success of such companies depends entirely on the results of research and clinical trials. This chart shows forecasts for the cancer treatment sector. It provides context for understanding the risks and potential rewards in this field.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Cancer-cure&v=1772543745164 "Graph of future (predicted) profits of companies in a market segment - Cancer cure")
Future (predicted) profit of the market as a whole
The forecast in this chart determines the availability of funding for early-stage biotech companies. Advanced Biomed, which specializes in cancer treatment, is critically dependent on capital inflows. An economic recovery and risk appetite facilitate capital raising, while a recession and risk aversion can halt research.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772543745170 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Advanced Biomed Inc
Advanced Biomed is an early-stage biotech company. This metric, with minimal revenue, is a pure measure of expectations. It reflects the value the market places on the scientific prospects of its cancer treatment developments.
P/S market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company focused on developing cancer treatments. This chart shows the average valuation in the oncology sector. It serves as a benchmark for investors, allowing them to assess how the market perceives Advanced Biomed's scientific developments and their potential compared to other companies operating in this field.
P/S of the market as a whole
Advanced Biomed Inc. is a biopharmaceutical company developing cancer treatments. The company is in early research, and its value is based on the potential of its scientific discoveries. This chart, reflecting real revenue estimates, highlights the high degree of risk and uncertainty in early biotech.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Advanced Biomed Inc
Advanced Biomed is a biopharmaceutical company focused on developing cancer treatments. Its valuation, like many early-stage companies, depends almost entirely on future success in clinical trials. The chart reflects investors' speculative bets on its scientific platform and potential future revenue.
%20P%2FS%20Advanced%20Biomed%20Inc&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Advanced-Biomed-Inc&v=1772543745283 "The graph of the company's future (projected) P/S Advanced Biomed Inc")
Future (projected) P/S of the market segment - Cancer cure
Advanced Biomed is likely a biotech company working on developing new cancer treatments. The success of such companies depends entirely on the results of clinical trials. This chart reflects investor expectations for its research portfolio and potential breakthroughs in oncology compared to other biotech companies.
%20P%2FS%20market%20segment%20graph%20-%20Cancer%20cure&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Cancer-cure&v=1772543745309 "Future (projected) P/S market segment graph - Cancer cure")
Future (projected) P/S of the market as a whole
This chart reflects expectations for the biotech sector. For Advanced Biomed, a company developing cancer treatments, this is an indicator of the investment climate. Market optimism allows for raising funds for expensive research that could lead to the development of new anticancer drugs.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772543745391 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Advanced Biomed Inc
Advanced Biomed Inc. is a biopharmaceutical company focused on developing drugs for the treatment of oncology. This chart reflects revenue from partnerships and licensing. Future revenue is dependent on the successful completion of clinical trials and the commercialization of new cancer therapeutics.
Sales of companies in the market segment - Cancer cure
Advanced Biomed Inc. is likely a biotech company working on developing new cancer treatments. This chart shows financial activity in the oncology sector. The efforts of such companies to develop innovative drugs are a key driver of progress in the fight against cancer and shape the future of the entire industry.
Overall market sales
Advanced Biomed Inc. is a biopharmaceutical company focused on developing new cancer treatments. Its success depends entirely on clinical trial results and subsequent approval. The overall economic situation, shown in this chart, influences the investment climate in the biotech sector and the availability of capital.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Advanced Biomed Inc
Advanced Biomed is an early-stage biopharmaceutical company focused on developing new cancer treatments. Its future depends entirely on the success of preclinical and clinical trials. This chart reflects analysts' highly speculative expectations regarding the scientific potential of the company's assets.
%20sales%20of%20the%20company%20Advanced%20Biomed%20Inc&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Advanced-Biomed-Inc&v=1772543745609 "Schedule of future (projected) sales of the company Advanced Biomed Inc")
Future (projected) sales of companies in the market segment - Cancer cure
Advanced Biomed is a company developing cancer treatments. This chart reflects expectations for the entire oncology sector. It provides insight into the overall market growth potential and the investment climate in the development of new anti-cancer therapies, where the company is seeking to establish its niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Cancer-cure&v=1772543745738 "Schedule of future (projected) sales of companies in the market segment - Cancer cure")
Future (projected) sales of the market as a whole
Advanced Biomed Inc. is a biomedical company focused on developing new cancer treatments. Its valuation is based on the potential of its scientific developments and clinical candidates. The overall economic environment, reflected in this chart, influences the funding available to early-stage biotech companies, which is critical for their survival and growth.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772543745841 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Advanced Biomed Inc
Advanced Biomed is a biopharmaceutical company focused on developing new cancer treatments. This chart reflects its financial performance in the early stages of research. Negative values represent investments in research and development, the success of which determines the company's entire future value and profitability.
Market segment marginality - Cancer cure
Advanced Biomed Inc. is a biopharmaceutical company focused on developing cancer treatments. For a company in the research and development stage, this chart serves as an important indicator of potential. It shows the average profitability achieved in their sector, illustrating the financial target for successful drug commercialization.
Market marginality as a whole
Advanced Biomed is a biopharmaceutical company focused on developing cancer treatments. This overall profitability curve is not a determining factor for the company. Its future value depends on success in clinical trials and the ability to bring innovative drugs to market, not on current market conditions.
Employees in the company, segment and market as a whole
Number of employees in the company Advanced Biomed Inc
Advanced Biomed is an early-stage biopharmaceutical company focused on developing cancer treatments. This graph shows a very small team of scientists. This size is typical for a startup whose primary focus is the lab and preclinical research.
Share of the company's employees Advanced Biomed Inc within the market segment - Cancer cure
Advanced Biomed Inc., working to develop cancer drugs, requires a team of highly qualified scientists. In this field of biotechnology, human capital is everything. This metric reflects the percentage of leading oncologists, biologists, and chemists in its research niche that the company attracts, demonstrating its scientific potential and ambition.
Number of employees in the market segment - Cancer cure
Advanced Biomed is a biopharmaceutical company developing new cancer treatments. The fight against cancer is one of humanity's greatest challenges. This graph illustrates how science-intensive this field is, requiring the best oncologists, biologists, and chemists to find breakthrough solutions.
Number of employees in the market as a whole
Advanced Biomed Inc., focused on cancer treatment, is part of the global scientific frontier. Competition in this field is fierce, driving demand for top oncologists and biologists. This overall employment chart captures this elite segment of the labor market, where every new job is an investment in the future of medicine.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Advanced Biomed Inc (ADVB)
Advanced Biomed (ADVB) is a biotech company specializing in cancer treatment. This chart is a classic example of intellectual capital valuation. The company's value is based not on current sales, but on the potential of its scientific developments and pipeline of candidates. The chart shows the high future value the market attributes to this research, per scientist.
%20of%20the%20company%20Advanced%20Biomed%20Inc%20(ADVB)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Advanced-Biomed-Inc-ADVB&v=1772543746457 "Chart of market capitalization per employee (in thousands of dollars) of the company Advanced Biomed Inc (ADVB)")
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer cure
Advanced Biomed is a biotech company working on cancer treatments. Like many of its peers, its value is based on expectations of future breakthroughs. The chart shows how the market values the potential of its research team. Comparisons with the industry provide insight into whether its scientific approach is considered particularly promising.
%20by%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Cancer-cure&v=1772543746470 "Market capitalization per employee (in thousands of dollars) by market segment - Cancer cure")
Market capitalization per employee (in thousands of dollars) for the overall market
Advanced Biomed Inc. is a biopharmaceutical company developing cancer treatments. This chart shows the market-wide per-employee performance valuation, highlighting how the market views the potential of new oncology therapies.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772543746503 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Advanced Biomed Inc (ADVB)
Advanced Biomed is a clinical-stage biotech company focused on cancer treatment. The company has no commercial products. This chart shows the net loss per employee. It reflects how much the company invests in each scientist for R&D.
%20Chart%20Advanced%20Biomed%20Inc%20(ADVB)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Advanced-Biomed-Inc-ADVB&v=1772543746515 "Company Profit Per Employee (in thousands of dollars) Chart Advanced Biomed Inc (ADVB)")
Profit per employee (in thousands of dollars) in the market segment - Cancer cure
Advanced Biomed Inc. is a biopharmaceutical company focused on developing cancer treatments. Like many companies in clinical trials, its core asset is research and development. This graph likely shows negative earnings per employee, reflecting significant investment in its scientific team and long-term research in anticipation of commercial success.
%20in%20the%20market%20segment%20-%20Cancer%20cure&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Cancer-cure&v=1772543746538 "Chart of profit per employee (in thousands of dollars) in the market segment - Cancer cure")
Profit per employee (in thousands of dollars) for the market as a whole
Advanced Biomed (ADVB) — (Little info, micro-cap). Likely a biotech/medtech company in the R&D stage, focused on cancer treatment. This chart shows the average profitability per employee across the market. For ADVB (which is not yet profitable), this is a benchmark: in biotech, a small team of scientists can create a product that will significantly exceed this average in the future.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772543746564 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Advanced Biomed Inc (ADVB)
Advanced Biomed is a biomedical company working on cancer treatments. For a company in the development stage, this graph is an indicator of future potential. It reflects the team's goal: to transform scientific discoveries into a commercial product capable of generating significant revenue per employee.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Advanced-Biomed-Inc-ADVB&v=1772543746579 "Sales chart per company employee Advanced Biomed Inc (ADVB)")
Sales per employee in the market segment - Cancer cure
Advanced Biomed (ADVB) is a clinical-stage biotech company focused on developing cancer treatments. Revenue is not yet available. This chart shows the average revenue per employee in the segment, which serves as a benchmark for commercial pharmaceutical companies. It provides context for assessing the effectiveness of ADVB's workforce in the industry.
Sales per employee for the market as a whole
Advanced Biomed — *Data for the ticker symbol ADVB is unclear. Based on the "Cancer Cure" category*. This is a clinical-stage biotech company focused on cancer treatment. The company has no commercial revenue, so this metric is irrelevant. Their entire value lies in the potential of their R&D team to create a new drug.
Short shares by company, segment and market as a whole
Shares shorted by company Advanced Biomed Inc (ADVB)
Advanced Biomed (ADVB) is a very early, preclinical stage biotech company trying to develop cancer treatments. It's a highly speculative venture bet. This chart shows the number of investors who believe the company's chances of bringing its product to market are close to zero and that it will run out of money.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Advanced-Biomed-Inc-ADVB&v=1772543746796 "Short Shares Chart for the Company Advanced Biomed Inc (ADVB)")
Shares shorted by market segment - Cancer cure
Advanced Biomed Inc. is an early-stage biopharmaceutical company developing cancer treatments. This chart reflects the overall short position in the biotech sector. High values indicate general investor skepticism about the success of risky early-stage clinical trials, which are common across the oncology industry.
Shares shorted by the overall market
Advanced Biomed is an early-stage biotech company focused on cancer treatment. This chart measures overall fear. When investors are pessimistic, microcap biotech stocks suffer first. Liquidity in ADVB shares dries up, and investors are unwilling to take on the risk of clinical trial failure, preferring to retreat to safer assets.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Advanced Biomed Inc (ADVB)
Advanced Biomed Inc. is a biotech company working on cancer treatments. Like many in the sector, the company's shares react sharply to news. This oscillator measures the strength of these reactions, helping to identify when investor enthusiasm (above 70) or fear (below 30) reaches extremes.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Advanced-Biomed-Inc-ADVB&v=1772543746890 "RSI 14 indicator chart for the company's stock Advanced Biomed Inc (ADVB)")
RSI 14 Market Segment - Cancer cure
Advanced Biomed Inc. is a biotech company specializing in developing cancer treatments. This chart measures the collective excitement in the oncology biotech sector. It helps investors assess whether the entire industry is under pressure or, conversely, overbought on the back of clinical trial news.
RSI 14 for the overall market
For Advanced Biomed, a biotech company in the R&D stage, this chart is a lifeline showing capital availability. During moments of market euphoria, investors are willing to "buy the dream" and fund breakthrough but risky research. When the market panics, the money supply is shut off, and cash-burning companies face a liquidity crisis.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast ADVB (Advanced Biomed Inc)
Advanced Biomed (ADVB) is an early-stage biotech focused on developing cancer treatments. This chart shows the average 12-month analyst price target. For such a company, the target price is a collective speculative bet on the success of their scientific platform.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-ADVB-Advanced-Biomed-Inc&v=1772543746995 "A chart showing analyst consensus forecasts for the expected stock price. ADVB (Advanced Biomed Inc)")
The difference between the consensus estimate and the actual stock price ADVB (Advanced Biomed Inc)
Advanced Biomed is a biotech company focused on developing cancer treatments. This chart shows the difference between the market valuation and the consensus estimate. For an R&D company, this gap reflects analysts' faith in their scientific platform and the likelihood of clinical success.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-ADVB-Advanced-Biomed-Inc&v=1772543747006 "A chart showing the difference between the consensus forecast and the actual stock price. ADVB (Advanced Biomed Inc)")
Analyst consensus forecast for stock prices by market segment - Cancer cure
Advanced Biomed is a clinical-stage biotech company focused on R&D (development) of new cancer treatments. This chart reflects analysts' overall expectations for the entire cancer treatment sector. It shows whether experts believe junior biotechs are successful or consider the sector overheated.
Analysts' consensus forecast for the overall market share price
Advanced Biomed is an early-stage holding company specializing in biotechnology investments, particularly in cancer treatment. This chart reflects the overall market "risk appetite." For ADVB, a high-risk company whose value is based on future expectations, overall market optimism (risk appetite) is critical to raising the capital needed for research.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Advanced Biomed Inc
Advanced Biomed is likely an R&D biotech company focused on developing cancer drugs. This chart is a pure indicator of faith in their R&D. It doesn't reflect revenue, but rather a speculative estimate of their (very risky) pipeline and their clinical trial data.
AKIMA Market Segment Index - Cancer cure
Advanced Biomed (ADVB) is likely an early-stage biopharmaceutical company focused on developing new treatments for cancer and other serious diseases. The chart shows the segment's average index, helping investors assess how this company compares to the average risk in the drug development sector.
The AKIM Index for the overall market
Advanced Biomed is a Taiwanese biotech company developing microfluidic technologies for early cancer detection (liquid biopsy). This chart, showing the average (global/US) market share, serves as a benchmark. It helps assess how ADVB, a diagnostics startup, stacks up against overall macroeconomic trends.
